Daniel Catenacci, MD

As an adult medical oncologist, Daniel Catenacci, MD, specializes in the treatment of gastrointestinal malignancies. He provides skilled care for a range of conditions, including esophageal, gastric, pancreatobiliary, liver (hepatocellular carcinoma), colorectal, appendiceal, neuroendocrine (carcinoid), and anal cancers. Dr. Catenacci works with a multi-disciplinary team of surgical oncologists, radiation oncologists, and medical oncologists to provide the most optimal care possible for cancer patients.

An active basic and clinical researcher, Dr. Catenacci is involved in bench-to-bedside translational research. He conducts basic investigations on normal and cancer cell signaling with the ultimate goal of developing new inhibitory drugs for the treatment of gastroesophageal cancer and other digestive malignancies. Additionally, Dr. Catenacci designs and executes clinical trials based on laboratory findings and discoveries. Early in his training, he completed a William J. von Liebig Summer Research Fellowship at the Harvard Institutes of Medicine.